Cytokeratin 5 anticorps
(2 références)-
- Antigène Voir toutes Cytokeratin 5 (KRT5) Anticorps
- Cytokeratin 5 (KRT5) (Keratin 5 (KRT5))
-
Reactivité
- Humain
-
Hôte
-
Cobaye
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp Cytokeratin 5 est non-conjugé
-
Application
- Western Blotting (WB), Immunohistochemistry (Paraffin-embedded Sections) (IHC (p)), Immunohistochemistry (Frozen Sections) (IHC (fro))
- Pureté
- Stabilized antiserum
- Immunogène
- Cytokeratin 5 antibody was raised in guinea pig using recombinant human keratin K5 as the immunogen.
- Top Product
- Discover our top product KRT5 Anticorps primaire
-
anti-Keratin 5 (KRT5) (AA 316-590) antibody
KRT5 Reactivité: Humain WB, IHC, ELISA, FACS Hôte: Souris Monoclonal 10C11E6 unconjugated
anti-Keratin 5 (KRT5) antibodyKRT5 Reactivité: Humain, Souris, Singe WB, IHC, ELISA, FACS, ICC Hôte: Souris Monoclonal 2C2 unconjugated
anti-Keratin 5 (KRT5) (AA 335-473) antibodyKRT5 Reactivité: Rat WB, IHC, IP, ICC Hôte: Lapin Polyclonal unconjugated
anti-Keratin 5 (KRT5) (AA 258-357) antibodyKRT5 Reactivité: Humain WB, IHC, ELISA, FACS, ICC Hôte: Souris Monoclonal 2C8E4 unconjugated
anti-Keratin 5 (KRT5) (AA 258-357) antibodyKRT5 Reactivité: Humain, Souris, Singe WB, IHC, ELISA, FACS, ICC Hôte: Souris Monoclonal 3D6D4 unconjugated
anti-Keratin 5 (KRT5) (AA 316-590) antibodyKRT5 Reactivité: Humain IHC, StM Hôte: Souris Monoclonal KRT5-3594 unconjugated
anti-Keratin 5 (KRT5) antibodyKRT5 Reactivité: Humain WB, IHC, IF, IP Hôte: Lapin Polyclonal unconjugated
anti-Keratin 5 (KRT5) (AA 1-273) antibodyKRT5 Reactivité: Humain WB, IHC, IHC (p) Hôte: Souris Monoclonal 4A7 unconjugated
anti-Keratin 5 (KRT5) (AA 163-471) antibodyKRT5 Reactivité: Souris WB, IHC, IP, ICC Hôte: Lapin Polyclonal unconjugated
anti-Keratin 5 (KRT5) (AA 331-430) antibodyKRT5 Reactivité: Humain, Souris, Rat WB, ELISA, FACS, IHC (p), IF (cc), IF (p), IHC (fro) Hôte: Lapin Polyclonal unconjugated
-
- Indications d'application
- IHC-F: 1:100, IHC-P: 1:50, WB: 1:5,000-1:10,000
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- Lot specific
- Buffer
- Suppleid as a liquid with 0.09 % NaN3 and 0.5 % BSA.
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains sodium azide as preservative. Although the amount of sodium azide is very small appropriate care must be taken when handling this product.
- Stock
- 4 °C
- Stockage commentaire
- Store at 4 °C
-
-
: "Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4." dans: Nature communications, Vol. 10, Issue 1, pp. 5546, (2020) (PubMed).
: "p73 regulates epidermal wound healing and induced keratinocyte programming." dans: PLoS ONE, Vol. 14, Issue 6, pp. e0218458, (2019) (PubMed).
-
: "Syngeneic animal models of tobacco-associated oral cancer reveal the activity of in situ anti-CTLA-4." dans: Nature communications, Vol. 10, Issue 1, pp. 5546, (2020) (PubMed).
-
- Antigène
- Cytokeratin 5 (KRT5) (Keratin 5 (KRT5))
- Autre désignation
- Cytokeratin 5 (KRT5 Produits)
- Synonymes
- anticorps 3300001P10Rik, anticorps AW146334, anticorps CK5, anticorps K5, anticorps Krt2-5, anticorps Tfip8, anticorps DDD, anticorps DDD1, anticorps EBS2, anticorps KRT5A, anticorps Sak57, anticorps ckii, anticorps wu:fb02h09, anticorps wu:fj02d02, anticorps wu:fk78b12, anticorps zfCKII, anticorps KRT75, anticorps CK-5, anticorps Keratin-5, anticorps keratin 5, anticorps Krt5, anticorps KRT5, anticorps krt5
-
